방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 전두엽 기능 평가 배터리× | 알츠하이머병 평가 척도-인지 (ADAS-Cog)× | |
|---|---|---|
| 분야 | 신경심리학 | 신경심리학 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 2000 | 1984 |
| 창시자≠ | Bruno Dubois | William Rosen |
| 유형≠ | Clinician-administered neuropsychological battery for frontal lobe function | Clinician-administered cognitive scale for Alzheimer's disease |
| 원전≠ | Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626. DOI ↗ | Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364. DOI ↗ |
| 별칭≠ | FAB, Frontal Battery | ADAS-Cog, ADAS-Cog14, ADAS-Cog13 |
| 관련 | 5 | 5 |
| 요약≠ | The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function. | The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months. |
| ScholarGate데이터셋 ↗ |
|
|